Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-07-10 DOI:10.3324/haematol.2024.286719

Hirotoshi Sakaguchi,Kimiyoshi Sakaguchi,Itaru Kato,Hisashi Noma,Hidefumi Hiramatsu,Hiroyuki Ishida,Hiromasa Yabe,Hiroaki Goto,Yuta Kawahara,Yuka Iijima Yamashita,Masashi Sanada,Takao Deguchi,Yoshiyuki Takahashi,Akiko M Saito,Masatoshi Takagi,Keisuke Okuno,Takashi Taga,Keizo Horibe,Yasuhiro Okamoto,Katsuyoshi Koh,Atsushi Manabe,Katsutsugu Umeda

引用次数: 0

Abstract

Not available.

查看原文本刊更多论文

移植后维持使用blinatumumab治疗复发和难治性b细胞急性淋巴细胞白血病的儿童、青少年和年轻人：SCT-ALL-BLIN21的I期研究结果

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.